Babak Moazen1,2*
Nasrul Ismail3Nisreen Agbaria1,2
Sara Mazzilli4
Davide Petri4Arianna Amaya1Jemima D’Arcy5Emma Plugge5,6
Lara Tavoschi4
Heino Stöver2- 1Heidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany
- 2Department of Health and Social Work, Institute of Addiction Research (ISFF), Frankfurt University of Applied Sciences, Frankfurt, Germany
- 3School for Policy Studies, University of Bristol, Bristol, United Kingdom
- 4Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy
- 5UK Health Security Agency, London, United Kingdom
- 6Primary Care, Population Sciences and Medical Education, Faculty of Medicine, University of Southampton, Southampton, United Kingdom
Background: Despite the elevated risks of infection transmission, people in prisons frequently encounter significant barriers in accessing essential healthcare services in many countries. The present scoping review aimed to evaluate the state of availability and model of delivery of vaccination services within correctional facilities across the globe.
Methods: Following the methodological framework for scoping reviews and adhering to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) extension for scoping reviews criteria, we conducted a systematic search across four peer-reviewed literature databases (Medline via PubMed, Web of Science, the Cochrane Library, Science Direct, and EBSCO), as well as 14 sources of grey literature. Two researchers meticulously examined the identified papers independently to extract pertinent data published between 2012 and 2022. The quality of the selected publications was assessed using established quality assessment tools.
Results: Of the 11,281 identified papers 52 met the inclusion criteria. With the exception of one, all the included publications presented data from high-income countries, predominantly originating from the United States. Across the world, the most prevalent vaccines available in prison settings were COVID-19 and HBV vaccines, typically distributed in response to health crises such as pandemics, epidemics, and local outbreaks. Vaccine coverage and uptake rates within correctional facilities displayed noteworthy disparities among various countries and regions. Besides, individual and organizational barriers and facilitating factors of vaccination in prison settings emerged and discussed in the text.
Discussion: The lack of vaccination services combined with low rates of vaccination coverage and uptake among people living and working in correctional facilities represents a cause for concern. Prisons are not isolated from the broader community, therefore, efforts to increase vaccine uptake among people who live and work in prisons will yield broader public health benefits.
Introduction
Globally, over 11.5 million people are living in prisons and other places of detention on any day (1). People living in prisons (PLP) often lack access to adequate healthcare services in many countries (2). This situation not only represents a violation of their right to health but also contradicts international agreements such as the “the United Nations Standard Minimum Rules for the Treatment of Prisoners” commonly known as “the Nelson Mandela Rules” (3). The Nelson Mandela Rules clearly stipulate that “The provision of health care for prisoners is a State responsibility. Prisoners should enjoy the same standards of health care that are available in the community, and should have access to necessary health-care services free of charge without discrimination on the grounds of their legal status” (3). Yet, the lack of availability of healthcare services coupled with individual risk factors render PLP susceptible to various infectious diseases. This vulnerability is substantiated by the alarmingly elevated prevalence of infectious diseases among PLP, worldwide (4).
The recent COVID-19 pandemic has brought to light the sluggish and inadequate responses to controlling infection transmission in many prisons across the globe. Multiple past influenza outbreaks within prison facilities have resulted in numerous fatalities, underscoring the susceptibility of PLP to airborne diseases (5, 6). Moreover, since the outset of the COVID-19 pandemic, various stakeholders, including international organizations, prison healthcare professionals, scientists, and activists, had cautioned prison systems about the looming COVID-19 crisis on a global scale (7, 8). Nonetheless, the alarmingly elevated number of COVID-19 cases in prisons (9) serves as a glaring indicator of the inadequate response to the disease in numerous countries.
Although previous reviews have occasionally addressed vaccination in prison settings (10–13), there are still numerous aspects of vaccination in prisons that remain largely under-researched. This review is a part of the “Reaching the hard to reach: Increasing access and vaccine uptake among prison populations in Europe (RISE-Vac)” project co-funded by the European Union, aimed at enhancing the health status of people in Europe by increasing vaccine uptake among people who live and work in prisons in this region. Aligned with the aims and objectives of the RISE-Vac, the present review was conducted to map the following: (a) the availability, accessibility, and coverage of vaccination services, (b) models of vaccine delivery, and (c) to explore the perceived barriers and determinants of vaccine uptake and refusal in prisons.
Methods
Methodology of the current review is published elsewhere extensively (14). Co-funded by the European Commission, the research initiative RISE-Vac aims to increase the rates of vaccine uptake within European prisons. Its objectives consist of identifying gaps in vaccine coverage, improving vaccine knowledge among PLPs and prison staff, and facilitating the transferability of the project’s health models and knowledge. Nine European partners from six countries participate in the RISE-Vac consortium: Germany, France, Italy, Moldova, Cyprus, and the United Kingdom. Detailed information about the project is available on the project’s website.1
Data identification
This review adhered to the methodological framework for scoping reviews (15) and the PRISMA extension for scoping reviews (16). The data collection process comprised three key phases: first, a comprehensive literature search was conducted to explore both peer-reviewed and gray literature sources. Secondly, a public call for data was announced and disseminated through various platforms, including the Worldwide Prison Health Research and Engagement Network’s (WEPHREN) website, as well as social media channels, e.g., X (Twitter) and LinkedIn to access potential information not publicly available. Lastly, a system outreach was distributed via email among the international network of the authors as well as members of the RISE-Vac advisory board. The RISE-Vac advisory board comprises experienced researchers, prison health policymakers, healthcare providers, stakeholders affiliated with national, regional, and global organizations engaged in prison health, as well as experts who have personal experience of incarceration.
Search strategy
Our search strategy was methodically executed across five distinct databases to identify peer-reviewed publications: Medline via PubMed, Web of Science, the Cochrane Library, Science Direct, and EBSCO. The goal was to procure insights into interventions geared toward increasing vaccine uptake within correctional facilities. In the pursuit of the optimal search query, a comprehensive exploration of Medical Subject Headings (MeSH), Entry terms, and non-MeSH keywords was undertaken. Subsequently, we settled upon the following search combination for our PubMed inquiry: ((Prison* OR Inmate OR Inmates OR Penitentiaries OR Penitentiary OR Jail OR Jails OR Detention Center OR incarcerat*) AND (Vaccin* OR Immunization)). The search terms were adapted for each database, given their unique search algorithms.
We expanded our search to scrutinize 14 gray literature sources, including WHO, CDC, ECDC, UNODC, WEPHREN, ResearchGate, Google, and Google Scholar. Tailored search terms were employed for each website to maximize precision. Particularly in Google, a wide array of terms, including vaccine-preventable diseases, were methodically combined with incarceration-related terms, with distinct combinations for each search.
Inclusion/exclusion criteria and quality assessment
Although the initial database searches were conducted in English, publications in other languages were also identified and scrutinized. Inclusion criteria encompassed papers published in peer-reviewed scientific journals or gray literature between January 1, 2012, and December 31, 2022, reporting information on vaccination services for people who live and work in prisons. Conversely, papers published prior to 2012, those focused on pre-or post-incarceration periods, and those with no pertinent information were excluded. Our review imposed no restrictions regarding the age of the study participants, correctional setting types, or locations. Third reviewers (EP and LT) were consulted when discrepancies arose during the assessment. Additionally, for quality assessment we employed the National Institute of Health’s tools for quantitative research and the Critical Appraisal Skills Program checklist for qualitative research to evaluate the quality of the included papers.
Data classification and analysis
We systematically extracted, categorized, and presented the key variables including publication year, location (country/region), scope, total prison population, sample size of study, publication type, type of setting, target population characteristics, model of delivery of the vaccination services (services are offered by who, where, and when), target diseases, and challenges encountered during implementation of the vaccination services in prisons. In this review, ‘coverage’ is used to denote the percentage of individuals who have received at least one dose of vaccine before their incarceration, while ‘uptake’ is used to indicate the percentage of individuals who have received at least one dose of vaccine while in detention centers.
Results
General characteristics of the included studies
Of the 11,281 reviewed publications, 52 studies published between 2012 and 2022 met the inclusion criteria (Figure 1). The majority of the included publications were peer-reviewed in forms of original articles (35/52), followed by brief reports (10/52), research letters (4/52), opinion paper (1/52), case report (1/52), and research abstract (1/52). Most of the included publications came from high-income countries including the US (27/52), the UK (6/52), Canada (4/52), Italy (4/52), Australia (2/52), France (2/52), Switzerland (2/52), Spain (1/52), and Sweden (1/52). Aside from the high-income countries, we found data from only one middle income country: Thailand (1/52). Two included publications reported data at regional levels, both from Europe (one publication reporting data from seven countries, namely Spain, Northern Ireland, Ireland, Poland, Finland, Sweden, and the other from the EU/EEA countries). General characteristics of the included studies are presented in Table 1.
Figure 1. PRISMA chart of the included studies.
Table 1. Worldwide availability and model of vaccine delivery and uptake in prisons from 2012 to 2022.
Quality of the included studies
Based on our assessment, none of the included studies were reporting high-quality evidence. Level of evidence was moderate-to-high in 3 publications, moderate in majority of the included publications (32/52), and low in 17 publications.
Settings and samples
Sample size of the included studies varied widely from 46 to 164,283 participants. The included studies reported data from various settings including prisons (25/52), jails (10/52), various facilities combined (3/52), and other facilities, e.g., juvenile detention centers (14/52). Type of setting was not reported in one study. In the majority of the included publications, adult PLP were the main target population of the vaccination programs (36/52), followed by PLP and staff members combined (10/52), juvenile (3/52), and staff only (2/52). Target population was not reported in one publication. In 20 out of 52 publications, the gender of the target population was reported. Among these, the majority included both males and females (13 out of 20), while six publications focused solely on males, and one publication exclusively on females.
Availability of vaccination services by country
Included articles reported on vaccination programs in prisons covering various diseases including COVID-19 (17/52), HBV (10/52), HPV (6/52), influenza (5/52), measles (3/52), varicella (3/52), HAV (2/52), pneumonia (1/52), diphtheria (1/52), or two or more diseases combined (4/52). The countries implementing vaccination programs in prisons comprise Australia (measles, HBV), Canada (influenza, COVID-19, varicella), France (HBV), Italy (measles, COVID-19, HBV), Spain (HAV, HBV, Tdap, pneumonia, influenza), Sweden (HPV), Switzerland (HAV, Tdap, polio, MMR, HBV, HPV), Thailand (Tdap), the UK (HBV, influenza, measles), and the US (HPV, COVID-19, HAV, HBV, Tdap, MCV4, varicella, influenza, pneumonia). One of the papers reporting data at regional level reported that COVID-19 vaccines were available and offered in Spain, Northern Ireland, Poland, Finland, Ireland, and Sweden. According to the other regional publication, except in Bulgaria, Latvia, Lithuania and Romania, HBV vaccines were available in all EU/EEA countries. Figure 2 shows the availability of vaccines in prisons by country, region, and type of vaccine.
Figure 2. Availability of vaccines in prison settings by country, region, and type of vaccine from 2012 to 2022.
Model of delivery of vaccination services in prisons
According to the included publications, in two European countries, Czech Republic and Sweden, HBV vaccines are offered only to at-risk populations (e.g., men who have sex with men (MSM)). In the Netherlands, HBV vaccines are offered only upon request by physicians. In Germany, nine out of the 16 states offered HBV vaccines to all eligible people, while five states offered the vaccines only to at-risk populations. HBV vaccines are available on an opt-in basis in one state in Germany.
Despite the lack of data, vaccines have reportedly been delivered in prisons by internal or external providers including clinical and non-clinical prison staff members, community healthcare workers, e.g., nurses and attending physicians, and researchers (in case the vaccination program was part of a research project). No study reported data on the time (e.g., immediately after admission or during incarceration) and location of delivery of vaccines in prisons.
In 25/52 included publications, the program was implemented as a response to existing health crises such as pandemics, epidemics, or local outbreaks. In one of the implemented interventions at the time of outbreak of influenza, only PLP in affected living units received the vaccines. In addition, evidence shows that in 6/52 settings offering vaccines there was no routine vaccination programs in place and vaccines were offered only for research purposes.
Rates of vaccination coverage and uptake in prisons
Data on vaccination coverage among people who live and work in prisons were reported in 14 publications. Very low levels of coverage (0–25%) were reported from Spain, the UK, and the US; low levels (26–50%) from Finland, Ireland, Switzerland, the UK, and the US; moderate levels (51–75%) from Canada, France, Poland, Spain, Sweden, Switzerland, the UK, and the US; and high levels (76–100%) from Estonia, Northern Ireland, Spain, and the US (Table 2).
Table 2. Rates of vaccination coverage among PLP from 2012 to 2022§.
Data on vaccine uptake among people who live and work in prisons were reported in 28 included publications. Very low levels of uptake (0–25%) were reported from Italy, Spain, Sweden, the UK, and the US; low levels (26–50%) from Australia, Sweden, the UK, and the US; moderate levels (51–75%) from France, Italy, the UK, and the US; and high levels (76–100%) from Canada, Italy, the UK, and the US (Table 3).
Table 3. Rates of vaccination uptake among PLP from 2012 to 2022§.
Factors facilitating vaccine delivery and uptake in prisons
At an individual level, higher levels of education, knowledge of vaccine and disease, vaccination being offered free of charge, recommendation from trusted individuals, history of vaccination, history of contracting infectious diseases, gender, living in shared housing, the offer of incentives to get vaccinated, immunization status of family members and friends, race, and cues to action were reported to be the facilitators of vaccine uptake among PLP. For staff members, older age, race (white and black), belief in safety and efficacy of vaccines, and protection of the community were found to be the facilitators of vaccine uptake. At an organizational level, availability of vaccines and type of facility (living in a prison rather than other facilities) were reportedly facilitators of vaccine uptake.
Barriers toward vaccine delivery and uptake in prisons
Barriers toward vaccine uptake in adult PLP at an individual level included cost of vaccines, concerns of safety and efficacy, concerns of confidentiality, pain from needle, distrust in prison staff members, recommendation from people other than physicians, female gender, race (non-Hispanic black, Asian, American-Indian, and Alaska native), social pressure and social responsibility, religious and moral convictions, being foreign national, and lack of incentive. For juvenile PLP, limited parental involvement to increase vaccine uptake, distrust in prison staff members, being influenced by adults who express mistrust, need to secure parental consent, low perceived risk, and often brief duration of detention were reportedly the main barriers to vaccine uptake. Among staff members, younger age, history of infection, living in a community with low rates of vaccination, sharing shifts with coworkers with low rates of vaccination, being a healthcare worker, concerns of safety and efficacy of vaccine, and rushed timelines were found to be the barriers toward vaccine uptake.
At an organizational level, high turnover of PLP, long delay in receiving serological results and release of PLP, delay in vaccine supply by the manufacturer, strict public health measures, shortage of staff members, lack of protocols, lack of transportation, distance, and necessity to provide advanced notice to probation officers were reportedly the barriers toward vaccination offer and uptake in prisons, worldwide.
Discussion
Our review revealed that evidence regarding the availability of vaccination services in prisons primarily originates from high-income countries. However, data on the accessibility, acceptability, quality, and the delivery models of vaccination services in prison settings remain limited. Vaccine coverage and uptake rates within prisons exhibit significant variations across different countries and regions. COVID-19 vaccination stood out as the most frequently reported vaccine in prisons, underscoring the lack of attention given to other vaccine-preventable diseases within correctional facilities worldwide. Due to the paucity of data, the coverage and uptake of vaccines in prisons exhibit substantial disparities depending on the country and the specific type of vaccine. Notably, many of the included publications indicated that vaccination services were typically implemented during times of crises such as pandemics, epidemics, and local disease outbreaks. This highlights the absence of routine vaccination programs within the prison systems across the globe. Moreover, our investigation identified various individual and organizational barriers that hinder the provision and uptake of vaccines within prison settings worldwide.
The findings of this review align with previous studies (10, 11) and underscore the limited availability of vaccines in prisons and the low vaccination coverage among PLP. Our review has highlighted that certain countries primarily offer vaccination services during crises such as epidemics and pandemics. Furthermore, it is important to note that in some cases, not all people living in a prison receive vaccines, but rather, only those in affected living units (21). Vaccines are recognized as one of the most effective preventive measures for reducing the incidence, morbidity, hospitalization, and mortality associated with infectious diseases within correctional facilities (69). However, relying solely on vaccination as a responsive strategy during crises could undermine its overall effectiveness in mitigating the health and financial burdens of infectious diseases in prison settings.
Having knowledge about vaccines and infectious diseases was identified as a significant facilitator for vaccine uptake among incarcerated people. On the other side, misinformation and disinformation are among the major factors hindering vaccine uptake, as observed widely during the COVID-19 pandemic across the world. In this regard numerous studies have shown the negative association between vaccine hesitancy and level of knowledge as well as between vaccine hesitancy and behavioral intention (70, 71). As social contacts are one of the most common sources of health information among PLP (72), the risk of dissemination of misleading information about healthcare services, e.g., vaccination is high. Some community-based recommendations, e.g., active participation of healthcare professionals to address misleading information (73) can be adapted and implemented in prison settings as well. This should be taken into consideration that immediate response plays a crucial role in tackling infodemics (74).
Vaccine hesitancy, however, is multifaceted and goes beyond misleading information alone. Various multicomponent dialog-based interventions have been recommended to address vaccine hesitancy in the community (75). These recommendations include but not limited to targeting specific populations, e.g., unvaccinated or under-vaccinated; increasing knowledge and awareness on vaccines; enhancing access and convenience of vaccination services; to engage influencing people in the program; embedding vaccination services in routine healthcare practices and procedures; and addressing mistrust in healthcare providers and institutions through engagement and dialog (75). While these recommendations are primarily designed for the general population, they can also be applied in correctional settings to enhance vaccine uptake among people who live and work within prisons.
Various interventions have been implemented to address vaccine hesitancy and to increase vaccine uptake in prison settings around the world. These interventions are mostly focused on information dissemination through educational interventions including courses with or without panel discussions, posters, factsheets, pamphlets, etc. (14). In addition to the educational interventions, some countries have implemented organizational interventions including implementing the vaccination programs by external healthcare providers, applying accelerated vaccination schedules for hepatitis B, modifying the vaccination protocols to offer vaccines at the time of entrance, and prioritizing PLP for vaccination implemented by the governments. As evidence on the effectiveness of the aforementioned interventions is scarce (14), these interventions should be implemented cautiously.
Overcrowding stands as one of the most pervasive issues and a significant contributor to substandard prison conditions on a global scale, which, in turn, significantly compromises the quality of healthcare services within correctional facilities. Evidence shows that prisons in 118 countries currently exceed their maximum occupancy limits (76). In the United States, for instance, overcrowding has resulted in inmates having to sleep in gyms, hallways, and even triple-and quadruple-bunked in their cells (77). Numerous strategies, as recommended in the literature, can be employed to mitigate overcrowding within prison settings. These strategies include diverting minor cases away from the criminal justice system; enhancing access to justice and improving case management during pre-trial detention; fostering the development and implementation of constructive non-custodial measures and sentences; reducing sentence lengths while ensuring a consistent approach to sentencing; and establishing avenues for parole or other forms of early release, along with comprehensive post-release support to deter recidivism (78). Applying these measures can effectively alleviate overcrowding and, consequently, enhance the quality of healthcare services, including the administration of vaccinations, in prisons worldwide.
The recently-published WHO framework for assessing prison health system performance has been developed to assist countries in enhancing their prison health systems (79). To achieve this objective, the framework outlines five key priorities: strengthening prison information systems to improve surveillance and response capacity; monitoring health service provision within correctional facilities; tracking and evaluating system performance; acquiring valid and reliable measures of the health status of incarcerated individuals; and engaging in intersectoral collaboration to enhance overall performance and outcomes. Incorporating these components into the design and implementation of healthcare services, including vaccination programs, will significantly enhance the quality and sustainability of these services.
People who work in prisons can play a significant role in bringing the infectious diseases, in specific airborne diseases, from the community to prisons and vice versa. Yet, the health assessment of people who work in prisons has historically been overlooked. During the COVID-19 pandemic, for example, low vaccination rates among prison staff members were reported from many countries (59, 80). Evidence also shows that in many countries implementing COVID-19 vaccination programs prison staff members were not among the priority groups to receive the vaccine (81). Besides that, in our review we found 10/52 publications including both people who live and work in prisons and only 2/52 publications targeting prison staff alone. The lack of publication is another factor highlighting the lack of attention to prison staff members as a key population in prisons. It should be considered that prison-based vaccination plans excluding people who work in prisons would be incomplete and suboptimal.
Task shifting entails the purposeful redistribution of tasks to healthcare providers with fewer qualifications, extending beyond their traditional scope of work (82). When supported by strong evidence and executed efficiently, task shifting can significantly enhance health outcomes and contribute to the long-term sustainability of healthcare systems (83). In particular, task shifting has demonstrated its effectiveness and viability in managing infectious diseases (84, 85). Given that a shortage of human resources is a primary obstacle to delivering optimal healthcare services within correctional facilities, the adoption of task shifting, involving non-medical staff members in healthcare service delivery, is anticipated to offer a solution for enhancing the quality and long-term sustainability of healthcare services including vaccination in prison settings.
Strengths and limitations of the review
This review is, to our knowledge, the first of its kind classifying and reporting on the characteristics of the existing vaccination programs in prisons in the world. However, results of the present review should be seen in light of some limitations. Lack of published data on various aspects of vaccination in prisons is one of the main limitations of the current review and, on a broader scale, one of the most important barriers toward taking evidence-based decisions on prison health globally. The neglected aspects of vaccination in prisons comprise gender and racial disparities in vaccine uptake and hesitancy; subpopulations of PLP, e.g., the LGBTQ+, older adults, and those living with chronic conditions; determinants of vaccine uptake and refusal; and strategies to increase vaccine uptake in places of correction. Lack of quality was another main limitation of this review, as none of the included studies were found to be reporting high-quality evidence. In our review we addressed these limitations using a multistage search strategy, applying a wide range of inclusion/exclusion criteria, and taking advantage of the established quality assessment tools.
Recommendations and future directions
We propose the following recommendations are made to enhance the quality of vaccination services in prison settings, to address vaccine hesitancy, and to increase the rates of vaccine uptake among people who live and work in prisons:
• To establish more valid and reliable data that can inform prison policy-makers and enhance the effectiveness and quality of the vaccination services in prison settings, funding organizations should expand their support on prison health research, and prison policy-makers should facilitate data collection in prison settings.
• To address mistrust and distrust of vaccination among prison staff members, health providers should take forward the implementation of vaccination services and related interventions, e.g., knowledge dissemination.
• To fight against infodemics, policymakers should capitalize the knowledge of lived experience to provide PLP with reliable and updated information through peer-led educational activities and ensure they are able to make an informed decision on vaccination.
• Implementing mandatory interventions including vaccination, or putting sanctions/restrictions for not using services, is violation of the rights of PLP as human beings; therefore, use of the entire healthcare services in prison settings must be voluntarily with no obligation. At the same time, evidence-based strategies should be in place to facilitate access to services and increase service uptake.
• Policymakers should undertake needs assessment to identify the needs of populations and subpopulations of PLP before implementing vaccination services. All interventions should be tailored based on the needs of the target populations considering their age, gender, race, sexual orientation, and cultural diversity.
• Monitoring and evaluation should be in place to track the effectiveness of the implemented vaccination interventions in prisons. Routine monitoring and evaluation will help prison policymakers and healthcare providers identify the gaps and find solutions to address the possible problems.
• High turnover and short duration of stay is one of the contributing factors preventing PLP from finishing vaccination schedules of vaccines requiring more than one dose. Therefore, there is a need for a referral system to ensure completion of vaccine schedules among people with unfinished vaccination schedules after release.
• The immunization status of those who work in prisons should be checked before and during their employment on a regular basis.
Conclusion
In this review we evaluated over 11,000 publications and found that very few countries, worldwide, offer vaccines to people who live and work in prisons. The most frequently-offered vaccine in prison settings was COVID-19, underlining the lack of attention to the other vaccine-preventable diseases in prisons during the past decade. Similarly, the vast majority of the included publications came from high-income countries and regions, highlighting the abandonment of prison health in low-and middle-income settings. It should be considered that over 90% of PLP will eventually return to their communities. On the other side, prison staff members commute daily between prisons and communities. Therefore, providing accessible, acceptable, affordable and high-quality vaccination services for people who live and work in prisons is a public health investment. Apart from their public health aspects, provision of healthcare services in prison settings is an effort toward reaching international targets such as the UN sustainable development goal 3 of ensuring healthy lives and promoting well-being for all.
Data availability statement
The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author.
Author contributions
BM: Conceptualization, Investigation, Methodology, Software, Supervision, Visualization, Writing – original draft, Writing – review & editing. NI: Conceptualization, Investigation, Methodology, Writing – review & editing. NA: Conceptualization, Investigation, Methodology, Writing – review & editing. SM: Conceptualization, Investigation, Methodology, Writing – review & editing. DP: Conceptualization, Investigation, Visualization, Writing – review & editing. AA: Conceptualization, Investigation, Validation, Visualization, Writing – review & editing. JD'A: Conceptualization, Investigation, Methodology, Validation, Writing – review & editing. EP: Conceptualization, Investigation, Methodology, Supervision, Validation, Writing – review & editing. LT: Conceptualization, Funding acquisition, Investigation, Methodology, Project administration, Supervision, Writing – review & editing. HS: Conceptualization, Investigation, Methodology, Project administration, Supervision, Validation, Writing – review & editing.
Funding
The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This study was supported by European Union. This study was co-funded by the Third Health Programme of the European Union (2014-2020). RISE-Vac project Grant Number 101018353.
Acknowledgments
The authors extend their sincere gratitude to the UK Health Security Agency and the esteemed members of the RISE-Vac advisory board for their invaluable assistance and unwavering support in the collection of data.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Footnotes
References
1. Institute for Crime & Justice Policy Research . World prison population list. 13th ed. London: Institute for Crime & Justice Policy Research (2021).
2. Kamarulzaman, A , Reid, SE , Schwitters, A , Wiessing, L , El-Bassel, N , Dolan, K, et al. Prevention of transmission of HIV, hepatitis B virus, hepatitis C virus, and tuberculosis in prisoners. Lancet. (2016) 388:1115–26. doi: 10.1016/S0140-6736(16)30769-3
3. United Nations General Assembly . The United Nations standard minimum rules for the treatment of prisoners. Vienna: United Nations (2015).
4. Dolan, K , Wirtz, AL , Moazen, B , Ndeffo-Mbah, M , Galvani, A , Kinner, SA, et al. Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees. Lancet. (2016) 388:1089–102. doi: 10.1016/S0140-6736(16)30466-4
5. Awofeso, N . Prisons show prophylaxis for close contacts may indeed help in next flu pandemic. BMJ. (2004) 329:173.4. doi: 10.1136/bmj.329.7458.173-c
6. Foppiano Palacios, C , Openshaw, JJ , and Travassos, MA . Influenza in U.S. detention centers – the desperate need for immunization. N Engl J Med. (2020) 382:789–91. doi: 10.1056/NEJMp1916894
7. Kinner, SA , Young, JT , Snow, K , Southalan, L , Lopez-Acuña, D , Ferreira-Borges, C, et al. Prisons and custodial settings are part of a comprehensive response to COVID-19. Lancet Public Health. (2020) 5:e188–9. doi: 10.1016/S2468-2667(20)30058-X
8. Simpson, PL , and Butler, TG . COVID-19, prison crowding, and release policies. BMJ. (2020) 369:m1551. doi: 10.1136/bmj.m1551
9. Vicente-Alcalde, N , Ruescas-Escolano, E , Franco-Paredes, C , and Tuells, J . Control of a COVID-19 outbreak in a Spanish prison: lessons learned in outbreak control. Front Med (Lausanne). (2022) 9:806438. doi: 10.3389/fmed.2022.806438
10. Madeddu, G , Vroling, H , Oordt-Speets, A , Babudieri, S , O'Moore, É , Noordegraaf, MV, et al. Vaccinations in prison settings: a systematic review to assess the situation in EU/EEA countries and in other high income countries. Vaccine. (2019) 37:4906–19. doi: 10.1016/j.vaccine.2019.07.014
11. Vicente-Alcalde, N , Ruescas-Escolano, E , Harboe, ZB , and Tuells, J . Vaccination coverage among prisoners: a systematic review. Int J Environ Res Public Health. (2020) 17:7589. doi: 10.3390/ijerph17207589
12. Ismail, N , Tavoschi, L , Moazen, B , Roselló, A , and Plugge, E . COVID-19 vaccine for people who live and work in prisons worldwide: a scoping review. PLoS One. (2022) 17:e0267070. doi: 10.1371/journal.pone.0267070
13. Sequera, VG , and Bayas, JM . Vaccination in the prison population: a review. Rev Esp Sanid Penit. (2012) 14:99–105. doi: 10.4321/S1575-06202012000300005
14. Moazen, B , Agbaria, N , Ismail, N , Mazzilli, S , Klankwarth, UB , Amaya, A, et al. Interventions to increase vaccine uptake among people who live and work in prisons: a global multistage scoping review. J Community Psychol. (2023). 1–17. doi: 10.1002/jcop.23077
15. Arksey, H , and O’Malley, L . Scoping studies: towards a methodological framework. Int J Soc Res Methodol Theory Pract. (2005) 8:19–32. doi: 10.1080/1364557032000119616
16. Tricco, AC , Lillie, E , Zarin, W , O'Brien, KK , Colquhoun, H , Levac, D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. (2018) 169:467–73. doi: 10.7326/M18-0850
17. Allison, M , Musser, B , Satterwhite, C , Ault, K , Kelly, P , and Ramaswamy, M . Human papillomavirus vaccine knowledge and intention among adult inmates in Kansas, 2016-2017. Am J Public Health. (2018) 108:1000–2. doi: 10.2105/AJPH.2018.304499
18. Allison, M , Emerson, A , Pickett, ML , and Ramaswamy, M . Incarcerated Adolescents' attitudes toward human papillomavirus vaccine: report from a juvenile Facility in Kansas. Glob Pediatr Health. (2019) 6:2333794X19855290. doi: 10.1177/2333794X19855290
19. Beck, CR , Cloke, R , O'Moore, É , and Puleston, R . Hepatitis B vaccination coverage and uptake in prisons across England and Wales 2003-2010: a retrospective ecological study. Vaccine. (2012) 30:1965–71. doi: 10.1016/j.vaccine.2012.01.020
20. Berk, J , Murphy, M , Kane, K , Chan, P , Rich, J , and Brinkley-Rubinstein, L . Initial SARS-CoV-2 vaccination uptake in a correctional setting: cross-sectional study. JMIRx Med. (2021) 2:e30176. doi: 10.2196/30176
21. Besney, J , Moreau, D , Jacobs, A , Woods, D , Pyne, D , Joffe, AM, et al. Influenza outbreak in a Canadian correctional facility. J Infect Prev. (2017) 18:193–8. doi: 10.1177/1757177416689725
22. Biondi, BE , Leifheit, KM , Mitchell, CR , Skinner, A , Brinkley-Rubinstein, L , and Raifman, J . Association of State COVID-19 vaccination prioritization with vaccination rates among incarcerated persons. JAMA Netw Open. (2022) 5:e226960. doi: 10.1001/jamanetworkopen.2022.6960
23. Borthwick, C , O'Connor, R , and Kennedy, L . Predicting and understanding seasonal influenza vaccination behaviour among forensic mental health inpatients. Psychol Health. (2021) 36:1235–59. doi: 10.1080/08870446.2020.1846038
24. Brinkley-Rubinstein, L , Peterson, M , Martin, R , Chan, P , and Berk, J . Breakthrough SARS-CoV-2 infections in prison after vaccination. N Engl J Med. (2021) 385:1051–2. doi: 10.1056/NEJMc2108479
25. Chatterji, M , Baldwin, AM , Prakash, R , Vlack, SA , and Lambert, SB . Public health response to a measles outbreak in a large correctional facility, Queensland, 2013. Commun Dis Intell Q Rep. (2014) 38:E294–7.
26. Chin, ET , Leidner, D , Zhang, Y , Long, E , Prince, L , Li, Y, et al. Effectiveness of the mRNA-1273 vaccine during a SARS-CoV-2 Delta outbreak in a prison. N Engl J Med. (2021) 385:2300–1. doi: 10.1056/NEJMc2114089
27. Costumbrado, J , Stirland, A , Cox, G , El-Amin, AN , Miranda, A , Carter, A, et al. Implementation of a hepatitis a/B vaccination program using an accelerated schedule among high-risk inmates, Los Angeles County jail, 2007-2010. Vaccine. (2012) 30:6878–82. doi: 10.1016/j.vaccine.2012.09.006
28. Couper, S , Bird, SM , Foster, GR , and McMenamin, J . Opportunities for protecting prisoner health: influenza vaccination as a case study. Public Health. (2013) 127:295–6. doi: 10.1016/j.puhe.2012.12.004
29. Alves da Costa, F , Andersen, Y , and Ferreira-Borges, C . Success in vaccination efforts of vulnerable populations in the WHO/European region: focus on prisons. Front. Public Health. (2021) 9:738422. doi: 10.3389/fpubh.2021.738422
30. Emerson, A , Allison, M , Kelly, PJ , and Ramaswamy, M . Barriers and facilitators of implementing a collaborative HPV vaccine program in an incarcerated population: a case study. Vaccine. (2020) 38:2566–71. doi: 10.1016/j.vaccine.2020.01.086
31. Emerson, A , Allison, M , Saldana, L , Kelly, PJ , and Ramaswamy, M . Collaborating to offer HPV vaccinations in jails: results from a pre-implementation study in four states. BMC Health Serv Res. (2021) 21:309. doi: 10.1186/s12913-021-06315-5
32. Fusillo, C , Sinopoli, MT , Marchetti, C , Cervellini, P , Cirius, SM , Morucci, L, et al. Azienda sanitaria locale (ASL) Roma 4: experience of measles vaccination prophylaxis in a prison. Eur J Pub Health. (2018) 28:1101–262. doi: 10.1093/eurpub/cky218.135
33. Gahrton, C , Westman, G , Lindahl, K , Öhrn, F , Dalgard, O , Lidman, C, et al. Prevalence of Viremic hepatitis C, hepatitis B, and HIV infection, and vaccination status among prisoners in Stockholm County. BMC Infect Dis. (2019) 19:955. doi: 10.1186/s12879-019-4581-3
34. Gaskin, GL , Glanz, JM , Binswanger, IA , and Anoshiravani, A . Immunization coverage among juvenile justice detainees. J Correct Health Care. (2015) 21:265–75. doi: 10.1177/0885066615587790
35. Getaz, L , Casillas, A , Motamed, S , Gaspoz, JM , Chappuis, F , and Wolff, H . Hepatitis a immunity and region-of-origin in a Swiss prison. Int J Prison Health. (2016) 12:98–105. doi: 10.1108/IJPH-10-2015-0033
36. Di Giuseppe, G , Pelullo, CP , Lanzano, R , Napolitano, F , and Pavia, M . Knowledge, attitudes, and behavior of incarcerated people regarding COVID-19 and related vaccination: a survey in Italy. Sci Rep. (2022) 12:960. doi: 10.1038/s41598-022-04919-3
37. Goldman, PN , Szoko, N , Lynch, L , and Rankine, J . Vaccination for justice-involved youth. Pediatrics. (2022) 149:e2021055394. doi: 10.1542/peds.2021-055394
38. Hagan, LM , Dusseau, C , Crockett, M , Rodriguez, T , and Long, MJ . COVID-19 vaccination in the Federal Bureau of Prisons, December 2020–April 2021. Vaccine. (2021) 39:5883–90. doi: 10.1016/j.vaccine.2021.08.045
39. Hyatt, JM , Bacak, V , and Kerrison, EM . COVID-19 vaccine refusal and related factors: preliminary findings from a system-wide survey of correctional staff. Federal Sentencing Reporter. (2021) 33:272–7. doi: 10.1525/fsr.2021.33.4.272
40. Jacomet, C , Guyot-Lénat, A , Bonny, C , Henquell, C , Rude, M , Dydymski, S, et al. Addressing the challenges of chronic viral infections and addiction in prisons: the PRODEPIST study. Eur J Pub Health. (2016) 26:122–8. doi: 10.1093/eurpub/ckv183
41. Jeannot, E , Huber, T , Casillas, A , Wolff, H , and Getaz, L . Immunisation coverage among adolescents in a Swiss juvenile correctional facility. Acta Paediatr. (2016) 105:e600–2. doi: 10.1111/apa.13520
42. Junghans, C , Heffernan, C , Valli, A , and Gibson, K . Mass vaccination response to a measles outbreak is not always possible. Lessons from a London prison. Epidemiol Infect. (2018) 146:1689–91. doi: 10.1017/S0950268818001991
43. Khorasani, S , Zubiago, J , Carreiro, J , Guardado, R , and Wurcel, AG . Influenza vaccination in Massachusetts jails: a mixed-methods analysis. Public Health Rep. (2022) 137:936–43. doi: 10.1177/00333549211041659
44. Khorasani, SB , Koutoujian, PJ , Zubiago, J , Guardado, R , Siddiqi, K , and Wurcel, AG . COVID-19 vaccine interest among corrections officers and people who are incarcerated at Middlesex County jail, Massachusetts. J Urban Health. (2021) 98:459–63. doi: 10.1007/s11524-021-00545-y
45. Centers for Disease Control and Prevention . Severe influenza among children and young adults with neurologic and neurodevelopmental conditions – Ohio, 2011. MMWR Morb Mortal Wkly Rep. (2012) 60:1729–33.
46. Lessard, D , Ortiz-Paredes, D , Park, H , Varsaneux, O , Worthington, J , Basta, NE, et al. Barriers and facilitators to COVID-19 vaccine acceptability among people incarcerated in Canadian federal prisons: a qualitative study. Vaccine X. (2022) 10:100150. doi: 10.1016/j.jvacx.2022.100150
47. Leung, J , Lopez, AS , Tootell, E , Baumrind, N , Mohle-Boetani, J , Leistikow, B, et al. Challenges with controlling varicella in prison settings: experience of California, 2010 to 2011. J Correct Health Care. (2014) 20:292–301. doi: 10.1177/1078345814541535
48. Li, H , Cameron, B , Douglas, D , Stapleton, S , Cheguelman, G , Butler, T, et al. Incident hepatitis B virus infection and immunisation uptake in Australian prison inmates. Vaccine. (2020) 38:3255–60. doi: 10.1016/j.vaccine.2020.02.076
49. Liu, YE , Oto, J , Will, J , LeBoa, C , Doyle, A , Rens, N, et al. Factors associated with COVID-19 vaccine acceptance and hesitancy among residents of northern California jails. Prev Med Rep. (2022) 27:101771. doi: 10.1016/j.pmedr.2022.101771
50. Moore, A , Cox-Martin, M , Dempsey, AF , Berenbaum Szanton, K , and Binswanger, IA . HPV vaccination in correctional care: knowledge, attitudes, and barriers among incarcerated women. J Correct Health Care. (2019) 25:219–30. doi: 10.1177/1078345819853286
51. Moreau, D , Besney, J , Jacobs, A , Woods, D , Joffe, M , and Ahmed, R . Varicella zoster virus transmission in youth during incarceration. Int J Prison Health. (2016) 12:106–14. doi: 10.1108/IJPH-11-2015-0038
52. Murphy, M , Berns, AL , Bandyopadhyay, U , Rich, J , Quilliam, DN , Clarke, J, et al. Varicella in the prison setting: a report of three outbreaks in Rhode Island and a review of the literature. Vaccine. (2018) 36:5651–6. doi: 10.1016/j.vaccine.2018.07.031
53. Nakitanda, AO , Montanari, L , Tavoschi, L , Mozalevskis, A , and Duffell, E . Hepatitis B virus infection in EU/EEA and United Kingdom prisons: a descriptive analysis. Epidemiol Infect. (2021) 149:e59. doi: 10.1017/S0950268821000169
54. Ortiz-Paredes, D , Varsaneux, O , Worthington, J , Park, H , MacDonald, SE , Basta, NE, et al. Reasons for COVID-19 vaccine refusal among people incarcerated in Canadian federal prisons. PLoS One. (2022) 17:e0264145. doi: 10.1371/journal.pone.0264145
55. Parsons, TL , and Worden, L . Assessing the risk of cascading COVID-19 outbreaks from prison-to-prison transfers. Epidemics. (2021) 37:100532. doi: 10.1016/j.epidem.2021.100532
56. Perrett, SE , Craine, N , and Lyons, M . Developing blood borne virus services across prisons in Wales. UK Int J Prison Health. (2013) 9:31–9. doi: 10.1108/17449201311310788
57. Perrett, SE , Cottrell, S , and Shankar, AG . Hepatitis B vaccine coverage in short and long stay prisons in Wales, UK 2013-2017 and the impact of the global vaccine shortage. Vaccine. (2019) 37:4872–6. doi: 10.1016/j.vaccine.2019.02.065
58. Perrodeau, F , Pillot-Debelleix, M , Vergniol, J , Lemonnier, F , Receveur, MC , Trimoulet, P, et al. Optimizing hepatitis B vaccination in prison. Med Mal Infect. (2016) 46:96–9. doi: 10.1016/j.medmal.2016.01.002
59. Prince, L , Long, E , Studdert, DM , Leidner, D , Chin, ET , Andrews, JR, et al. Uptake of COVID-19 vaccination among frontline Workers in California State Prisons. JAMA Health Forum. (2022) 3:e220099. doi: 10.1001/jamahealthforum.2022.0099
60. Ramaswamy, M , Allison, M , Musser, B , Satterwhite, C , Armstrong, R , and Kelly, PJ . Local health department interest in implementation of a jail-based human papillomavirus vaccination program in Kansas, Iowa, Missouri, and Nebraska. J Public Health Manag Pract. (2020) 26:168–75. doi: 10.1097/PHH.0000000000001021
61. Ryckman, T , Chin, ET , Prince, L , Leidner, D , Long, E , Studdert, DM, et al. Outbreaks of COVID-19 variants in US prisons: a mathematical modelling analysis of vaccination and reopening policies. Lancet Public Health. (2021) 6:e760–70. doi: 10.1016/S2468-2667(21)00162-6
62. Sanchez, GV , Bourne, CL , Davidson, SL , Ellis, M , Feldstein, LR , Fay, K, et al. Pneumococcal disease outbreak at a state prison, Alabama, USA, September 1-October 10, 2018. Emerg Infect Dis. (2021) 27:1949–52. doi: 10.3201/eid2707.203678
63. Stasi, C , Monnini, M , Cellesi, V , Salvadori, M , Marri, D , Ameglio, M, et al. Screening for hepatitis B virus and accelerated vaccination schedule in prison: a pilot multicenter study. Vaccine. (2019) 37:1412–7. doi: 10.1016/j.vaccine.2019.01.049
64. Stasi, C , Monnini, M , Cellesi, V , Salvadori, M , Marri, D , Ameglio, M, et al. Ways to promote screening for hepatitis B virus and accelerated vaccination schedule in prison: training, information, peer education. Rev Epidemiol Sante Publique. (2022) 70:25–30. doi: 10.1016/j.respe.2022.01.001
65. Stern, MF , Piasecki, AM , Strick, LB , Rajeshwar, P , Tyagi, E , Dolovich, S, et al. Willingness to receive a COVID-19 vaccination among incarcerated or detained persons in correctional and detention facilities – four states, September-December 2020. MMWR Morb Mortal Wkly Rep. (2021) 70:473–7. doi: 10.15585/mmwr.mm7013a3
66. Tiamkao, S , Boonsong, A , Saepeung, K , Kasemsap, N , Apiwattanakul, M , Suanprasert, N, et al. An outbreak of peripheral neuropathy in a prison. Case Rep Neurol. (2019) 11:53–60. doi: 10.1159/000496536
67. Vicente-Alcalde, N , Tuells, J , Egoavil, CM , Ruescas-Escolano, E , Altavilla, C , and Caballero, P . Immunization coverage of inmates in Spanish prisons. Int J Environ Res Public Health. (2020) 17:8045. doi: 10.3390/ijerph17218045
68. Zellmer, L , Peters, L , and Silva, RS . Hennepin County adult detention Center's response to a 2019 hepatitis a outbreak in Minnesota. Am J Public Health. (2021) 111:839–41. doi: 10.2105/AJPH.2021.306159
69. Craig, MO , Kim, M , and Beichner-Thomas, D . Incarcerated in a pandemic: how COVID-19 exacerbated the “pains of imprisonment”. Crim Justice Rev. (2023). doi: 10.1177/07340168231190467
70. Pierri, F , Perry, BL , DeVerna, MR , Yang, KC , Flammini, A , Menczer, F, et al. Online misinformation is linked to early COVID-19 vaccination hesitancy and refusal. Sci Rep. (2022) 12:5966. doi: 10.1038/s41598-022-10070-w
71. Enders, AM , Uscinski, J , Klofstad, C , and Stoler, J . On the relationship between conspiracy theory beliefs, misinformation, and vaccine hesitancy. PLoS One. (2022) 17:e0276082. doi: 10.1371/journal.pone.0276082
72. Novisky, MA , Schnellinger, RP , Adams, RE , and Williams, B . Health information seeking behaviors in prison: results from the U.S. PIAAC survey. J Correct Health Care. (2022) 28:90–9. doi: 10.1089/jchc.20.04.0024
73. D'Amelio, AC , Cataldi, S , Dallagiacoma, G , Gentile, L , Odone, A , and Signorelli, C . Promoting societal resilience during the COVID-19 pandemic: a multi-country analysis of public health strategies. Acta Biomed. (2023) 94:e2023181. doi: 10.23750/abm.v94iS3.14562
74. Brashier, NM , Pennycook, G , Berinsky, AJ , and Rand, DG . Timing matters when correcting fake news. Proc Natl Acad Sci U S A. (2021) 118:e2020043118. doi: 10.1073/pnas.2020043118
75. Peters, MDJ . Addressing vaccine hesitancy and resistance for COVID-19 vaccines. Int J Nurs Stud. (2022) 131:104241. doi: 10.1016/j.ijnurstu.2022.104241
77. American Civil Liberties Union . Overcrowding and overuse of imprisonment in the United States. New York: American Civil Liberties Union (2015).
78. Penal Reform International . Ten-point plan to reduce prison overcrowding. London: Penal Reform International (2012).
79. World Health Organization . The WHO prison health framework: A framework for assessment of prison health system performance. Copenhagen: WHO Regional Office for Europe (2021).
80. Stanford Health Policy . CA prison staff have lower vaccine rates than those they oversee. Stanford, CA: Stanford University (2022).
81. Penal Reform International . COVID-19 vaccinations for prison populations and staff: Report on global scan. London: Penal Reform International (2021).
82. Leong, SL , Teoh, SL , Fun, WH , and Lee, SWH . Task shifting in primary care to tackle healthcare worker shortages: an umbrella review. Eur J Gen Pract. (2021) 27:198–210. doi: 10.1080/13814788.2021.1954616
83. European Commission . Task shifting and health system design: Report of the expert panel on effective ways of investing in health (EXPH). Luxembourg: Publications Office of the European Union (2019).
84. Oru, E , Trickey, A , Shirali, R , Kanters, S , and Easterbrook, P . Decentralisation, integration, and task-shifting in hepatitis C virus infection testing and treatment: a global systematic review and meta-analysis. Lancet Glob Health. (2021) 9:e431–45. doi: 10.1016/S2214-109X(20)30505-2
Keywords: infectious diseases, vaccination, immunization, primary prevention, prisons
Citation: Moazen B, Ismail N, Agbaria N, Mazzilli S, Petri D, Amaya A, D’Arcy J, Plugge E, Tavoschi L and Stöver H (2024) Vaccination against emerging and reemerging infectious diseases in places of detention: a global multistage scoping review. Front. Public Health. 12:1323195. doi: 10.3389/fpubh.2024.1323195
Edited by:
Huda Omer Basaleem, University of Aden, YemenReviewed by:
Lisa Puglisi, Yale University, United StatesFrancesca Prestinaci, National Institute of Health (ISS), Italy
Copyright © 2024 Moazen, Ismail, Agbaria, Mazzilli, Petri, Amaya, D’Arcy, Plugge, Tavoschi and Stöver. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Babak Moazen, YmFiYWsubW9hemVuQHVuaS1oZWlkZWxiZXJnLmRl